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Abstract
 
A role for Lyn kinase as a positive regulator of immunoglobulin (Ig)E-dependent allergy has
long been accepted. Contrary to this belief, Lyn kinase was found to have an important role as
a negative regulator of the allergic response. This became apparent from the hyperresponsive
degranulation of 
 
lyn
 
 
 
/
 
  
 
bone marrow–derived mast cells, which is driven by hyperactivation of
Fyn kinase that occurs, in part, through the loss of negative regulation by COOH-terminal Src
kinase (Csk) and the adaptor, Csk-binding protein. This phenotype is recapitulated in vivo as
young 
 
lyn
 
 
 
/
 
  
 
mice showed an enhanced anaphylactic response. In vivo studies also demon-
strated that as 
 
lyn
 
 
 
/
 
  
 
mice aged, their serum IgE increased as well as occupancy of the high
affinity IgE receptor (Fc
 
ε
 
RI). This was mirrored by increased circulating histamine, increased
mast cell numbers, increased cell surface expression of the high affinity IgE receptor (Fc
 
ε
 
RI),
and eosinophilia. The increased IgE production was not a consequence of increased Fyn kinase
activity in 
 
lyn
 
 
 
/
 
  
 
mice because both 
 
lyn
 
 
 
/
 
  
 
and 
 
lyn
 
 
 
/
 
  
 
fyn
 
 
 
/
 
  
 
mice showed high IgE levels.
Thus, 
 
lyn
 
 
 
/
 
  
 
mice and mast cells thereof show multiple allergy-associated traits, causing recon-
sideration of the possible efficacy in therapeutic targeting of Lyn in allergic disease.
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Introduction
 
The initiation of an allergic response requires the activa-
tion of mast cells and basophils and is primarily a conse-
quence of allergen-induced aggregation of the IgE-occupied
Fc
 
ε
 
RI. This aggregation initiates Lyn kinase–dependent
phosphorylation of Fc
 
ε
 
RI by transphosphorylation (1), a
process that likely depends on the receptors’ surrounding
lipid environment (2). This initial phosphorylation step is
essential for activation of the signal-amplifying Syk kinase
whose activity leads to the assembly of several plasma
membrane–localized macromolecular signaling complexes
that govern the biochemical signals responsible for initiating
mast cell degranulation and lymphokine responses (for re-
view see references 3 and 4). Because of its central role in
phosphorylating Fc
 
ε
 
RI, Lyn kinase has long been considered
a positive effector in the initiation of the allergic response.
However, several recent studies on B cells and monocytes
suggested that Lyn kinase has a negative regulatory role
because its absence resulted in the loss of phosphorylation
of several inhibitory molecules and/or loss of phosphatase
activity at the plasma membrane (5–7).
Bone marrow–derived mast cells (BMMCs) derived from
 
lyn
 
 
 
/
 
  
 
mice are not inhibited in their ability to degranulate
via Fc
 
ε
 
RI (8–10). This finding demonstrated Lyn kinase as
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Abbreviations used in this paper:
 
 BMMC, bone marrow–derived mast cell;
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dylinositol 3-OH kinase; PSA, passive systemic anaphylaxis; SCF, stem
cell factor; Src PTK, Src family protein tyrosine kinase. 
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dispensable for mast cell degranulation and altered the view
of the role of Lyn kinase in driving this response. Our previ-
ous studies showed that degranulation of Lyn-deficient mast
cells was hyperresponsive even though Fc
 
ε
 
RI phosphoryla-
tion was reduced (9, 11). On the other hand, degranulation
of Lyn-deficient mast cells depended on phosphatidylinosi-
tol 3-OH kinase (PI3K) activity, and was associated with
constitutive activation of PKC
 
  
 
(10). Subsequently, we
found that Fyn kinase was an upstream activator of PI3K
and in its absence BMMCs failed to degranulate (10). More-
over, the degranulation of both wild-type and Lyn-deficient
mast cells was effectively inhibited by the PI3K inhibitor,
LY294002 (10), consistent with the view that downstream
of Fc
 
ε
 
RI, positive regulation of mast cell degranulation is
Lyn independent but Fyn and PI3K dependent.
These findings, together with genetic evidence of Lyn
kinase as a negative regulator of IL-4 signaling (6), led us
to explore how Lyn kinase mediates negative control on
mast cell degranulation and whether its in vivo role reca-
pitulates negative regulation of allergic responses. Among
our findings, 
 
lyn
 
 
 
/
 
  
 
mice demonstrated several allergy-
associated traits including increased serum IgE, increased
circulating histamine, increased numbers of mast cells in
the skin and peritoneum, and increased expression of mast
cell Fc
 
ε
 
RI, consistent with the view that increased IgE en-
hances Fc
 
ε
 
RI expression, mast cell survival, and could lead
to mast cell degranulation (for review see reference 12; 13,
14). BMMCs from 
 
lyn
 
 
 
/
 
  
 
mice showed increased Fyn ki-
nase activity and were hypersensitive and hyperresponsive
due in part to the loss of appropriate targeting of COOH-
terminal Src kinase (Csk), which phosphorylates Src fam-
ily protein tyrosine kinases (Src PTKs) at a consensus
COOH-terminal tyrosine and promotes an inactive closed
conformation. Collectively, our findings show that Lyn
kinase plays a broad negative regulatory role in vivo that is
important for control of mast cell responsiveness and al-
lergy-associated traits.
 
Materials and Methods
 
Reagents and Antibodies.
 
DNP-specific mouse IgE was pro-
duced as previously described (15). DNP human serum albumin
(DNP-HSA; Ag; Sigma-Aldrich) was diluted in PBS before use.
Rabbit antibodies to Fyn (FYN3), Lyn (44), Hck (M28), Src
(N16), Csk-binding protein (Cbp), Csk, ERK2, and p38MAPK
were from Santa Cruz Biotechnology, Inc. Biotinylated antibody
to phosphotyrosine (4G10) was from Upstate Biotechnology. The
rabbit phospho-Src (Y418) and phospho-Lyn (Y507) antibodies,
which also recognize Fyn (Y417) and (Y528), were from Bio-
source International and Cell Signaling Technologies, respec-
tively. Immunoblotting antibodies to Cbp were provided by B.
Schraven (Magdeburg University, Magdeburg, Germany) and T.
Yamashita (Hokkaido University, Sapporo, Japan). Mouse anti–
phospho-ERK2 and rabbit anti–phospho-p38MAPK were from
Cell Signaling Technologies. Rabbit anti–phospho-Akt (Ser472/
473/474) was from BD Biosciences. Secondary antibodies or
reagents used for immunoblotting were: sheep anti–mouse IgG–
horseradish peroxidase (HRP) and donkey anti–rabbit IgG-
HRP (Amersham Biosciences), or Extravidin-HRP from Sigma-
Aldrich. The Src-selective inhibitor, PP2, was from Calbiochem.
For measurement of serum IgE levels, purified anti–mouse IgE
(clone R53-72), purified mouse IgE (
 
  
 
isotype control), biotin rat
anti–mouse IgE (clone R35-118), and streptavidin-HRP (SAv-
HRP) were purchased from BD Biosciences. ABTS peroxidase
substrate and peroxidase solution B were from KPL Gaithersburg.
The ELISA kit for serum histamine detection was from Beckman
Coulter/Immunotech.
 
Mice and In Vivo Experiments, Bone Marrow Isolation, and
BMMC Culture.
 
Mice used for these studies were as follows:
 
fyn
 
 
 
/
 
  
 
(SV129 
 
  
 
C57/BL6 [N2]); 
 
lyn
 
 
 
/
 
  
 
(SV129 
 
  
 
C57/BL6
[N7]); 
 
lyn
 
up/up 
 
(Y508F, SV129 
 
  
 
C57/BL6 [N2]; reference 7);
and 
 
lyn
 
 
 
/
 
  
 
fyn
 
 
 
/
 
 
 
, 
 
wt
 
, 
 
lyn
 
 
 
/
 
 
 
, and 
 
fyn
 
 
 
/
 
  
 
(SV129 
 
  
 
C57/BL6,
generated from 
 
fyn
 
 
 
/
 
  
 
[N2] 
 
  
 
lyn
 
 
 
/
 
  
 
[N2] mating). Mice were
maintained and used in accordance with National Institutes of
Health (NIH) guidelines and National Institute of Arthritis and
Musculoskeletal and Skin Diseases–approved animal study pro-
posal A001-04-03. Bone marrow was isolated from 5–6-wk-old
wild-type and gene-disrupted mice as previously described (16).
In vivo and cell responses of the gene-disrupted mice were com-
pared with age- and sex-matched litter mates. For in vivo studies,
most mice were used at an age of 4 or 7 wk. Limited numbers of
mice of 5, 8, 12, and 16 wk were used to confirm the relationship
of age to induction of allergic-like traits.
Peritoneal lavage was with 3 ml RPMI medium. Recovered
cells were analyzed for mast cell content and Fc
 
ε
 
RI expression
by staining with antibodies to KIT and Fc
 
ε
 
RI, or with an appro-
priate IgG isotype control as previously described (16). To de-
termine receptor occupancy, the mean fluorescence intensity of
recovered cells was compared before and after incubation with
exogenous DNP-specific IgE. Cytospins of the recovered peri-
toneal cells were stained with Wright-Giemsa to distinguish mast
cells, eosinophils, and monocytes. Passive systemic anaphylaxis
(PSA) challenge was performed essentially as previously de-
scribed (16). The concentration of serum IgE before challenge
was determined by ELISA and plasma histamine (anaphylaxis)
was measured by a competitive histamine ELISA (16). Signifi-
cance was determined by an unpaired 
 
t
 
 test using a 95% confi-
dence interval. BMMCs were grown in RPMI media supple-
mented with FBS, stem cell factor (SCF), and IL-3 as previously
described (16, 17). For BMMC cultures, Fc
 
ε
 
RI receptor expres-
sion was monitored weekly as previously described (16) and cells
were used for experiments when 
 
 
 
95% of the population was
Fc
 
ε
 
RI
 
 
 
. Cells were rested in the absence of serum, SCF, and IL-3
for 2–4 h before stimulation.
 
Ag Stimulation, Lysates, Immunoprecipitation, Immunoblots, and
PP2 Experiments.
 
3.0 
 
  
 
10
 
7 
 
cells were sensitized with DNP-
specific IgE for 2 h. Unless otherwise indicated, cells were stimu-
lated with 300 ng/ml Ag (DNP-HSA). Preparation of cell lysates,
immunoprecipitations, and immunoblotting procedures are de-
scribed elsewhere (18). Relative quantitation of immunoblots was
performed by densitometry. To determine the effect of PP2 on
mast cell degranulation and signaling, 2.5 
 
  
 
10
 
6 
 
(degranulation)
or 7.5 
 
  
 
10
 
6 
 
(MAPK and Akt phosphorylation) BMMCs were
incubated with a 10-
 
 
 
M concentration of PP2 for 15 min at
37
 
 
 
C before Ag stimulation at varying doses (degranulation) or
with 300 ng/ml (MAPK/Akt). After stimulation, degranulation
was measured as indicated below or cells for MAPK/Akt activa-
tion were pelleted by centrifugation and lysed in 250 
 
 
 
l SDS
sample buffer and proteins were resolved by SDS-PAGE fol-
lowed by transfer to nitrocellulose membranes.
 
Hexosaminidase Release Assay and Northern Blots.
 
Degranula-
tion was measured by assaying 
 
  
 
hexosaminidase release as previ- 
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ously described (16). For control, the supernatants of IgE-sensi-
tized mast cells not stimulated with Ag were used. Triplicate wells
were used for each condition and a minimum of three individual
experiments from at least two independent BMMC cultures were
performed. For Northern blots, total RNA was isolated from
wild-type, Lyn
 
 
 
/
 
 
 
, and Fyn
 
 
 
/
 
  
 
mast cells using TRIzol reagent
(Life Technologies). Agarose/formaldehyde gel electrophoresis of
RNA and transfer to the Zeta-Probe blotting membrane (Bio-
Rad Laboratories) was performed according to standard proce-
dure. The membranes were prehybridized and hybridized at 65
 
 
 
C
in PerfectHyb
 
TM 
 
Plus hybridization buffer (Sigma-Aldrich) over-
night with a Fyn cDNA probe encompassing nucleotides 15–480
or a cDNA of the entire 
 
  
 
actin gene (Lofstrand). After three
washes at room temperature in 2
 
  
 
SSC for 10 min, two stringent
washes were performed at 65
 
 
 
C for 30 min in 2
 
  
 
SSC, 0.2%
SDS. Blots were then subjected to autoradiography.
 
Retroviral Gene Transduction.
 
Bone marrow cells from femurs
of Lyn
 
 
 
/
 
  
 
mice were grown in the presence of IL-3 and SCF for
10 d. The retroviral packaging cells Phoenix-E and Bosc 23 (1:9
ratio) were mixed 24 h before transfection. Cells were transfected
using Fugene 6 (Roche) with an empty pMX vector (ve/ve) or
with wild-type Lyn in the pMX-pIE vector (re/re) containing a
green fluorescent protein (GFP) reporter. For infection, bone
marrow cells were cocultured with the packaging cells for 48 h.
The bone marrow cells were then harvested from the mixed cul-
ture and grown in IL-3 and SCF containing media (growth me-
dium) for 48 h before selection of transduced cells with 1.0 
 
 
 
g/
ml puromycin. After 14–21 d of selection, BMMCs were
screened for GFP and Fc
 
ε
 
RI expression. Typical cultures used for
analysis showed 
 
 
 
77 and 95% GFP or Fc
 
ε
 
RI expression, respec-
tively. Wild-type Lyn expression in transduced cells was 
 
 
 
1.5-
fold greater than in wild-type BMMCs.
 
In Vitro Kinase (IVK) Assays.
 
The activity of Src PTKs was
measured by an immune complex autophosphorylation assay. 3.0 
 
 
 
10
 
7 
 
BMMCs were lysed in RIPA buffer (10 mM NaH
 
2
 
PO
 
4
 
,
50 mM NaCl, 50 mM NaF, 0.5% deoxycholic acid, 0.05%
NaN
 
3
 
, 0.1% SDS, 1% Triton X-100, and 1 mM Na
 
3
 
VO4). Fyn,
Hck, and Src were immunoprecipitated with 5  g of the appro-
priate antibody prebound to protein A–sepharose for 3 h at
4 C. Immune-complexed proteins were recovered by centrifuga-
tion and washed twice with RIPA buffer followed by two addi-
tional washes with kinase buffer (50 mM Hepes, 0.1 mM
EDTA, 0.015% Triton X-100, 0.07% 2-mercaptoethanol, 10  M
Na3VO4, pH 7.0). The IVK reaction was started by resuspension
of the pellet in 30  l kinase buffer containing 10 mM ATP and
10 mM MgCl2. Samples were incubated at 30 C for 20 min with
vigorous mixing and reactions were stopped by addition of 30  l
2  SDS sample buffer and immediate boiling for 3 min. Protein
A–sepharose beads were removed by centrifugation and recov-
ered proteins were resolved by SDS-PAGE and transferred to ni-
trocellulose membranes. Autophosphorylation was detected by
antiphosphotyrosine blotting and protein loading was determined
by reprobing stripped membranes with the appropriate antibody.
Quantitation was by densitometry.
Online Supplemental Material. Figs. S1 and S2 showing in-
creased Fyn phosphorylation and protein as well as reconstitution
of Cbp phosphorylation by exogenous expression of Lyn in Lyn-
deficient mast cells, are available at http://www.jem.org/cgi/
content/full/jem.20040382/DC1.
Results
Lyn-deficient Mast Cells Show Increased Fyn Kinase Activity.
To explore the underlying mechanism for the observation
of increased degranulation in Lyn-deficient mast cells (10),
we examined the activity of several Src PTKs. Fyn, Hck,
and p60 Src (Src) have been demonstrated to be expressed
and/or activated upon FcεRI stimulation in either the mast
cell line, RBL-2H3, or in BMMCs (10, 19). Yes and Fgr
are minimally detected in BMMCs as determined by RT-
PCR and Western blotting (10). In IVK autophosphoryla-
tion assays, only Fyn kinase showed enhanced activity (Fig.
1 a) in Lyn-deficient mast cells. Fyn activity was constitu-
tively enhanced but was further increased by FcεRI stimu-
lation. This was also reflected by increased phosphorylation
of Fyn on Y417 (pY417), the regulatory tyrosine found in
the activation loop, relative to the COOH-terminal inhibi-
tory tyrosine, Y528 (pY528; Fig. S1 a, available at http://
www.jem.org/cgi/content/full/jem.20040382/DC1). In-
terestingly, the amount of Fyn protein was also slightly in-
Figure 1. Fyn kinase, but not Src kinase, activity is
constitutively increased in Lyn    mast cells. (a) Wild-
type or Lyn /  mast cells were stimulated with Ag for
the indicated time. Fyn kinase was immunoprecipitated
and subjected to an IVK reaction. Autophosphorylation
was measured by anti-phosphotyrosine (Anti-pY) immu-
noblotting and normalized for protein loading (Anti-Fyn).
(b) Conditions were identical to (a), however, p60 Src
was immunoprecipitated and subjected to IVK. Quantita-
tion was by densitometry. One representative experiment
is shown. Fold induction is the mean of three experi-
ments normalized to the wild-type (0 min) activity.Lyn Negatively Regulates the Allergic Response 1494
creased by an average of 1.3-fold in the absence of Lyn,
suggesting negative regulation of Fyn protein expression by
Lyn (Fig. S1 b). This was not caused by increased Fyn
mRNA expression because Northern blots showed no sig-
nificant difference in mRNA in Lyn-deficient and wild-
type cells (Fig. S1 c). Both the autophosphorylation assay
and pY417/pY528 analysis showed that the activity of Fyn
kinase in Lyn-deficient mast cells was  2.5–4-fold greater
than that seen in wild-type cells. Thus, the 30% increase in
Fyn protein does not explain the total increase in Fyn
activity. FcεRI-mediated activation of Src was found in
Lyn-deficient mast cells but was reduced compared with
wild-type mast cells (Fig. 1 b). Notably, we could not re-
producibly detect Hck protein and activity in Lyn-deficient
mast cells (not depicted).
Loss of Cbp Phosphorylation and Csk Interaction in Lyn-defi-
cient Mast Cells. To investigate possible mechanisms for
enhanced Fyn kinase activity, we explored the requirement
for Lyn in the phosphorylation and interaction of Cbp with
Csk, as this regulatory pathway has been intimately linked
to control of Src PTK activity (20, 21). As seen in Fig. 2 a,
immunoprecipitation of Cbp from wild-type mast cells re-
sulted in the coprecipitation of Lyn kinase. The association
of Lyn kinase with Cbp was largely unaffected by FcεRI
stimulation even though a slight reduction in associated
Lyn was consistently observed. Fyn kinase coprecipitation
was also detected, although this interaction appeared to be
weak and was not always observed. Consistent with a pre-
vious report (22), FcεRI stimulation of wild-type mast cells
increased phosphorylation of Cbp and also the binding of
Csk (Fig. 2 b). In contrast, Lyn-deficient mast cells showed
a marked inhibition (ranging from 67 to 92%) in the phos-
phorylation of Cbp. This loss of phosphorylation was not
restored by the possible redundancy of other Src PTKs
(23). Concomitant with the loss of Cbp phosphorylation, a
considerable loss (51–77%) of Csk interaction with Cbp
was also observed (Fig. 2 b). Similar results were obtained
by the inverse immunoprecipitation of Csk, which coim-
munoprecipitated Cbp from wild-type mast cells but
showed minimal Cbp coimmunoprecipitation from Lyn-
deficient mast cells (Fig. 2 c). The phosphorylation of Cbp
was found to be primarily Lyn dependent because Fyn-
deficient mast cells showed relatively normal phosphoryla-
tion of Cbp (and Csk interaction; Fig. 2 d).
Expression of Lyn Kinase in Lyn-deficient Mast Cells Causes
Cbp Phosphorylation, Down-regulates Fyn Kinase Activity, and
Restores Normal Levels of Degranulation. Mutation of the
negative regulatory tyrosine (Y508F) in Lyn kinase results
in a constitutively active form of this kinase capable of
phosphorylating its substrates in vivo (7, 24). Mast cells de-
rived from mice expressing this mutant form of Lyn
(lynup/up) were analyzed for the phosphorylation of Cbp. As
Figure 2. Lyn kinase, but not Fyn kinase, is required for tyrosine phosphorylation of Cbp. (a) Wild-type mast cells were stimulated with Ag for the
indicated time. Cbp was immunoprecipitated and recovered protein was probed for the presence of Lyn (Anti-Lyn) or Fyn (Anti-Fyn) kinases. A control
immunoprecipitation with normal rabbit IgG (rIgG) is also shown. Immunoblots were reprobed with anti-Cbp for protein loading. (b) Wild-type and
Lyn /  mast cells were stimulated as described above for the indicated time. Cbp was immunoprecipitated and resolved proteins were probed for tyrosine
phosphorylation (Anti-pY) or for Csk (Anti-Csk). (c) Cells were stimulated as described above and Csk was immunoprecipitated. Resolved protein was
immunoblotted for Cbp phosphorylation, Csk, or Cbp protein. (d) Wild-type, Lyn / , or Fyn /  mast cells were stimulated with Ag for the indicated
time. Cbp was immunoprecipitated and its tyrosine phosphorylation was determined by anti-pY blotting. Stripped immunoblots were then reprobed
with anti-Csk or anti-Cbp. Fold induction is the mean of three individual experiments from two BMMC cultures. For all panels, one representative of a
minimum of three experiments is shown.Odom et al. 1495
shown in Fig. S2 a (available at http://www.jem.org/cgi/
content/full/jem.20040382/DC1), expression of lynup/up re-
sulted in enhanced phosphorylation of Cbp. However,
analysis of the protein levels of Fyn kinase in lynup/up mast
cells revealed that expression of this constitutively active
form of Lyn caused a loss of Fyn protein (Fig. S2 b), mak-
ing an analysis of the effect of Lyn on Fyn activity difficult.
Therefore, Lyn-deficient mast cells were retrovirally trans-
duced with wild-type Lyn, which did not substantially de-
crease the expression of Fyn kinase (Fig. 3 a). Fig. 3 b
shows that the total activity of Fyn kinase in the Lyn retro-
virus–transduced cells was reduced and FcεRI-dependent
increases in Fyn activity were restored. Retroviral trans-
duction alone (vector) did not cause any significant change
in Fyn kinase activity. In three individual experiments, the
total activity of Fyn was reduced by 37–56% when wild-
type Lyn was transduced in Lyn-deficient mast cells. One
might predict that if Lyn kinase is essential for negative reg-
ulation of mast cell degranulation, expression of wild-type
Lyn kinase in Lyn-deficient mast cells should inhibit the
hyper-degranulation restoring it to the level of wild-type
cells. As shown in Fig. 3 c, expression of wild-type Lyn
(lynre/re) in Lyn-deficient mast cells restored control of de-
granulation and the observed response at all Ag concentra-
tions mirrored that of wild-type cells, whereas the response
of the vector-transduced cells (lynve/ve) was essentially iden-
tical to that of Lyn-deficient cells.
Lyn/Fyn-deficient Mice Are Resistant to PSA and BMMCs
from These Mice Are Impaired in Degranulation. To further
test the hypothesis that Fyn kinase activity was responsible
for the hyperresponsive degranulation phenotype of Lyn-
deficient mast cells, we generated lyn /  fyn /  double-
deficient mice. As shown in Fig. 4 a, Lyn or Fyn protein was
not detected in immunoblots of Lyn/Fyn double-deficient
Figure 3. Control of Fyn kinase activity and mast
cell degranulation is restored by retroviral transduction
of Lyn kinase in Lyn-deficient mast cells. (a) Lyn / 
mast cells were transduced (reconstituted) with wild-type
Lyn kinase (Lynre/re) or with a control vector (Lynve/ve).
Expression of Lyn and Fyn kinase was compared between
wild-type, Lyn / , Lynre/re, and Lynve/ve mast cells. Ex-
pression of endogenous Akt is shown for normalization.
(b) Wild-type, Lyn / , Lynre/re, and Lynve/ve mast cells
were stimulated with Ag for the indicated time. Fyn
kinase was immunoprecipitated and subjected to an
IVK assay. Autophosphorylation was detected by anti-pY
and stripped blots were reprobed with anti-Fyn. One
representative of three experiments is shown. Fold
induction is the mean of all experiments. (c) Degranu-
lation of wild-type Lyn-containing (Lynre/re), control
vector–containing (Lynve/ve), Lyn / , and wild-type
mast cells in response to the indicated Ag concentrations.
Net hexosaminidase release is reported as a percentage
of total. Data is from three individual experiments.Lyn Negatively Regulates the Allergic Response 1496
mast cells. As might be expected, Cbp phosphorylation in
Lyn/Fyn double-deficient mast cells was impaired (Fig. 4
b) similarly to Lyn-deficient mast cells. Analysis of the
FcεRI-dependent degranulation revealed that Lyn/Fyn
double-deficient mast cells were also defective in this re-
sponse (Fig. 4 c). The extent of degranulation was similar
to that observed for Fyn-deficient mast cells (10) and was,
at best, 20% of the response seen in wild-type cells (Fig. 4
c). However, Lyn/Fyn double-deficient mast cells were
able to degranulate to phorbol ester (PMA) and calcium
ionophore (A23187), which bypasses early signaling events,
demonstrating normal development of the secretory com-
partment (Fig. 4 c). Interestingly, the extent of the PMA/
A23187-induced degranulation mirrored that of Lyn-defi-
cient mast cells rather than that of wild-type cells (10), sug-
gesting that Lyn kinase may exert additional regulatory
controls on mast cell degranulation that are independent of
Fyn kinase.
Next, we explored whether the defective response of
Lyn/Fyn double-deficient mast cells was recapitulated in
vivo. PSA of lyn / , fyn-/-, and lyn /  fyn /  mice was ana-
lyzed. The initial experiments, in which mice of  8 wk of
age were used, showed that lyn /  mice were considerably
resistant ( 60% inhibited) to an anaphylactic challenge
(not depicted). However, as will become evident below,
the ability to sensitize these mice with Ag-specific IgE was
significantly impaired. In contrast, as shown in Fig. 4 d,
when mice of 4 wk of age were subjected to a PSA chal-
lenge, lyn /  mice showed a significant augmentation (P  
0.001) in their circulating histamine relative to wild-type
mice. The observed mean serum histamine concentration
for lyn /  mice was 16.8   0.6  M, whereas that of wild-
type mice was 12.0   0.4  M. In contrast, fyn /  and lyn / 
fyn /  mice (4 wk of age) were resistant. Upon PSA chal-
lenge, both fyn /  and lyn /  fyn /  mice showed levels of
circulating histamine that were 20% or less than in wild-
type mice. These results demonstrate that the in vitro mast
cell responses of each genotype are recapitulated in vivo.
Older Lyn-deficient Mice Have Increased Serum IgE, Increased
FcεRI Occupancy, Increased Serum Histamine, and Increased
Peritoneal Mast Cells and Eosinophils. The decreased ana-
phylactic response of older lyn /  mice led us to explore
the apparent discrepancy with the observed BMMC hyper-
responsiveness in our in vitro studies as well as with in-
creased in vivo anaphylactic response of young mice. The
most logical explanation is that the occupancy of FcεRI by
IgE would increase with the age of the mice based on the
observation that lyn /  mice were shown to have increased
levels of Igs and enhanced IL-4–dependent Ig class switch-
ing leading to IgE (5, 6, 25). Increased IgE production
Figure 4. In vitro and in vivo degranulation of wild-type and Lyn-deficient mast cells is Fyn kinase dependent. (a) Doubly deficient lyn /  fyn /  mice
were generated by initial mating of lyn /  and fyn /  mice. Whole cell lysates (WCL) from BMMCs derived from all genotypes were immunoblotted for
Fyn, Lyn, and FcεRI  (protein loading). (b) Wild-type and Lyn/Fyn /  deficient mast cells were stimulated with Ag for the indicated time. Cbp was
immunoprecipitated and its tyrosine phosphorylation was determined by anti-pY. Stripped blots were reprobed with anti-Cbp. (c) Degranulation of
wild-type, Lyn / , Lyn/Fyn / , and Fyn /  mast cells was determined, after stimulation with the indicated concentrations of Ag, by hexosaminidase
release. Net release as a percentage of total cellular hexosaminidase is shown. PMA/A23187 stimulation of Lyn/Fyn /  mast cells shows that these cells
have no intrinsic defect in the secretory apparatus. (d) In vivo passive systemic anaphylactic challenge of 4-wk-old wt, lyn / , fyn / , and lyn /  fyn / 
mice. Mice were passively sensitized with DNP-specific IgE (i.v.) and challenged 24 h later with DNP-HSA (Ag) or pseudochallenged with an equal
volume of saline for 1.5 min (i.v.). Plasma histamine concentration was measured by competitive ELISA. Significance for all data was determined by an
unpaired t test. ***, a p-value of  0.006.Odom et al. 1497
might preclude sensitization with Ag-specific IgE. Thus,
we first explored the relationship between the serum IgE
levels of lyn /  mice and the age of the mice. As shown in
Fig. 5 a, young lyn /  mice (4 wk of age) showed no sig-
nificant difference in circulating IgE levels when compared
with wild-type mice of up to 16 wk of age (0.23   0.04 vs.
0.31   0.05  g/ml), although a slight trend toward in-
creased levels of IgE was noted. However, by 7 wk of age,
lyn /  mice showed as much as a 10-fold increase in serum
IgE levels ranging from 0.98 to 5.8  g/ml when compared
with 7-wk-old wild-type mice (0.14–1.2  g/ml). This
suggested the possibility that as lyn /  mice aged, FcεRI
occupancy might vary from wild-type mice. Fig. 5 b shows
that FcεRI occupancy of peritoneal mast cells by IgE in-
creases with age for both wild-type and lyn /  mice. How-
ever, by 4 wk of age, lyn /  mice show FcεRI occupancy
levels similar to that of 7-wk-old wild-type mice. By 7 wk
of age, the FcεRI occupancy of lyn /  mice by IgE is al-
most complete. By 12–16 wk, lyn /  mice have no unoc-
cupied FcεRI (not depicted). Although wild-type mice at 7
wk showed an average of 22% of their mast cell FcεRI as
available for IgE binding, only 4% of these receptors are
available in lyn /  mice. Interestingly, wild-type mice of 16
wk of age showed an FcεRI occupancy of  86%. None-
theless, these mice respond to a PSA challenge similarly to
younger mice (not depicted), suggesting that to respond to
Ag-specific IgE,  4% but as little as 14% of the receptor
occupied by this IgE is required. This level of FcεRI avail-
ability for Ag-specific IgE is still seen in 4-wk-old lyn / 
mice, but not after 7 wk of age (Fig. 5 b).
Recent studies provide strong evidence for a role of mo-
nomeric IgE in increasing mast cell cytokines, survival, and
degranulation (under conditions where a large excess of
monomeric IgE is present or when negative regulatory con-
trol is lost in a mast cell; 13, 14, 26, 27). A correlation
between total serum IgE levels and histamine release in
vivo has also been demonstrated in several studies (28–30).
Therefore, we tested whether the increased serum IgE in
lyn /  mice could translate to increased serum histamine
based on the assumption that high concentrations of mono-
meric IgE could trigger mast cell degranulation or, alterna-
tively, that mice housed in a clean facility could still be ex-
posed to some environmental allergens. As seen in Fig. 5 c,
we obtained a statistically significant difference of approxi-
mately twofold in the serum histamine concentrations of
7-wk-old wild-type mice (mean   102.3   19.1 nM, n   8)
and lyn /  mice (mean   214.1   44.0 nM, n   8). A high
degree of correlation (r2   0.9517) was obtained for serum
IgE and histamine concentrations in the lyn /  mice (Fig. 5
d). In contrast, no correlation was found between the serum
IgE and histamine concentrations in 7–12-wk-old wild-
type mice (not depicted), suggesting that high concentra-
tions of monomeric IgE might be driving mast cell degranu-
lation in the lyn /  mice rather than the interaction of an
environmental allergen with allergen-specific IgE.
As stated above, increased concentrations of monomeric
IgE were shown to increase mast cell survival, but these
conditions also resulted in increased cell surface expression
of mast cell FcεRI (for review see reference 12), two fac-
tors associated with increased allergic responses. Therefore,
Figure 5. Lyn    mice show increased
serum IgE, increased FcεRI occupancy,
and increased circulating histamine. (a)
The serum IgE of 4- or 7-wk-old age-
and sex-matched unchallenged wt or
lyn /  mice was measured by ELISA.
(b) FcεRI occupancy of peritoneal mast
cells was determined from 4- or 7-wk-old
wt and lyn /  mice. The mean fluores-
cence intensity of cells before and after
incubation with exogenous IgE was
compared with obtained relative occu-
pancies. Data is shown as a percentage of
receptors available for binding of exoge-
nous IgE. (c) Plasma histamine concen-
tration of the mice in (a) was measured
by competitive ELISA. (d) Correlation
analysis of serum IgE and histamine
concentrations from lyn /  mice (data in
a and c). Significance for all data was
determined by an unpaired t test. ***, a
p-value of  0.003;  *, a p-value of
 0.03. Pearson r2   0.9517 for (d). A
total of five (b) or eight (a and c) mice
were used.Lyn Negatively Regulates the Allergic Response 1498
we investigated whether these factors might be observed in
7-wk-old lyn /  mice given their increased serum IgE. Fig.
6 a shows that mast cells in a peritoneal lavage of lyn / 
mice are increased, compared with wild-type mice of the
same age. Analysis on all tested mice revealed that perito-
neal mast cells of wild-type mice comprised, on average,
2.2% of the total cells in the peritoneal lavage (Fig. 6 b). In
contrast, lyn /  mice showed, on average,  5.3% as mast
cells (ranging from a low of 2.1 to a high of  11%). Re-
gardless of whether the numbers of peritoneal mast cells in
a given mouse were enhanced or not, all mast cells showed
increased cell surface FcεRI expression (Fig. 6 b). It should
be noted that lyn /  mice also showed increased numbers
of dermal mast cells, with 8.0   0.4 mast cells per field (a
magnification of 1,000) versus wild-type mice, which had
4.5   0.3 mast cells (P   0.001; not depicted). Impor-
tantly, 4-wk-old wild-type and lyn /  mice did not differ
significantly in peritoneal mast cell numbers with 1.3   0.4
and 1.7   0.3% of total cells as mast cells, respectively (not
depicted), even though the lyn /  mice showed a slight
trend toward increased mast cell numbers.
One of the consequences of in vivo mast cell activation
is the recruitment of eosinophils (31, 32). Therefore, we
investigated whether the number of eosinophils in the peri-
toneal lavage of 7-wk-old lyn /  mice was significantly dif-
ferent from that of wild-type mice. Fig. 6 c shows that a
striking eosinophilia is present in the peritoneum of lyn / 
mice. As compared with wild-type mice, where peritoneal
eosinophils are  2% of the cell population, lyn /  mice
had an average of  10% of total peritoneal cells as eosino-
phils (Fig. 6 c). Preliminary experiments showed no signifi-
cant difference in eosinophil numbers in the bone marrow
of lyn /  versus wild-type mice (not depicted), suggesting
that enhanced eosinophil proliferation and/or differentia-
tion in the bone marrow is not a likely explanation for the
peritoneal eosinophilia.
Given the high serum IgE concentrations in older lyn / 
mice and the enhanced Fyn kinase activity in mast cells
from these mice, we investigated whether Fyn might con-
tribute to the increased IgE phenotype. We measured the
serum IgE concentration of 7-wk-old wild-type, fyn / ,
lyn / , and lyn /  fyn /  mice. As shown in Fig. 6 d, fyn / 
Figure 6. Lyn    mice have increased numbers of peritoneal mast cells
with increased cell surface FcεRI expression and eosinophilia. Fyn is not
required for increased serum IgE. (a) Cells from a peritoneal lavage of wt
or lyn /  mice were stained with antibody to KIT and IgE after incuba-
tion with IgE to ensure FcεRI saturation. As a negative control, isotype-
specific IgG was also used to stain the cells. Inset numbers reflect the percentage of KIT/FcεRI  cells. (b) The percentage of mast cells in the peritoneum
and the mean fluorescence intensity of FITC-IgE staining (reflecting mast cell FcεRI expression) of all the mice analyzed (n   10). (c) Wright-Giemsa
stain of peritoneal lavage cells from wt or lyn /  mice. Mast cells are indicated by intense granule staining (dark cells, marked with arrow head), whereas
eosinophils show a light red/pink stain and multilobed/segmented nucleus (arrow, see inset in lyn /  sample). Graph is a quantitation of the percentage
of eosinophils found in the peritoneal lavage of all wt and lyn /  mice analyzed (n   10). (d) The serum IgE concentration of the indicated genotypes was
measured by ELISA from eight sex- and age-matched mice as described in Materials and Methods. Mean of the observed IgE concentrations for lyn / 
or lyn /  fyn /  mice is indicated by the line. No significant difference was found between these two populations, but both were significantly different
from wt or fyn /  mice. Significance was determined by an unpaired t test. ***, a p-value of  0.006; *, a p-value of  0.03.Odom et al. 1499
mice showed no significant difference in serum IgE levels
compared with wild-type mice. In contrast, the serum IgE
levels of lyn /  fyn /  mice were dramatically elevated and
identical to those of lyn /  mice. Dermal mast cell numbers
in  fyn /  mice (4.0    0.4 per field, a magnification of
1,000) were comparable to wild-type mice (4.5   0.3),
whereas those of lyn /  fyn /  mice (7.7   0.5) were com-
parable to lyn /  mice (8.0   0.4). This argues against the
possible loss of mast cells as an explanation for the loss of
anaphylactic responsiveness in the fyn /  and lyn /  fyn / 
mice. In contrast, it demonstrates a unique role for Lyn ki-
nase in down-regulating B cell IgE production, which is
independent of its control of Fyn kinase activity, and also in
controlling mast cell numbers in vivo. The important role
of Lyn in the IgE response is further supported by the in
vivo data shown in Fig. 6 d. The mice in these experiments
were generated from the initial mating of fyn /  and lyn / 
mice. Thus, the lyn alleles were solely contributed by the
fyn /  strain. This inheritance of lyn alleles from one parent
results in normal serum IgE levels regardless of whether fyn
alleles are present or not (Fig. 6 d, wt vs. fyn /  mice).
Thus, lyn alleles, but not fyn alleles, are essential for control
of B cell IgE production.
Discussion
Previous reports on the biochemical activity and re-
sponses of Lyn-deficient mast cells (8–10, 33) have
provided a glimpse of negative regulation in mast cell
signaling and responses. Here we explored the central
mechanism through which mast cells can degranulate in
the absence of Lyn kinase and investigated if Lyn exerts a
broad negative influence on the allergic response. The lat-
ter question is of critical importance because of the ac-
cepted view of Lyn kinase as a positive effector in mast cell
responses and thus as a possible therapeutic target in aller-
gic disease (34). We find that Fyn kinase activity is respon-
sible for the hyper-degranulation of Lyn-deficient mast
cells. This is seemingly independent of the background ge-
netics of the lyn /  mice or is a dominant feature of the
C57/BL6 background because mice backcrossed to C57/
BL6 for seven generations or mice of mixed background
(SV129     C57/BL6, N2) showed similar in vivo re-
sponses and their mast cells showed increased Fyn kinase
activity. The loss of phosphorylation of the membrane
scaffold adaptor, Cbp, plays an important role in the mast
cell hyperresponsiveness because membrane targeting of
the Src PTK negative regulatory kinase, Csk, is severely
impaired in Lyn-deficient mast cells, but this regulatory
pathway is restored by expression of Lyn. The essential na-
ture of Fyn in driving degranulation is evident in the lyn / 
fyn /  mouse, whose mast cells (both in vitro and in
vivo) showed severe impairment in degranulation. Inter-
estingly, lyn /  mice showed an increase in allergy-associ-
ated traits that was characterized by increased serum IgE,
increased circulating histamine, and eosinophilia, support-
ing the view of increased mast cell responsiveness in vivo.
Our findings show that inheritance of lyn alleles restores
normal control of these allergy-associated traits and that
fyn alleles play no apparent role in the control of these fac-
tors. These findings, together with our previous observa-
tion that in vivo expression of a Lyn gain of function mu-
tant (Y508F) resulted in down-regulation of serum IgE
levels (24), argue for the importance of Lyn kinase in con-
trolling allergy-associated risk factors.
Monomeric IgE in the context of a hypersensitive mast
cell (SHIP-1   ; reference 13), or incubation of wild-type
mast cells with high concentrations of certain monomeric
IgEs (14, 27), causes allergen-independent mast cell de-
granulation in vitro. High concentrations of monomeric
IgE in the context of a hypersensitive mast cell is recapitu-
lated in lyn /  mice. This suggests that the observed in-
crease in circulating histamine and the eosinophilia is a
possible consequence of mast cell activation, although this
still remains to be formally demonstrated. However, the
present findings are noteworthy as they establish a clear as-
sociation between the increasing age of lyn /  mice, in-
creasing serum IgE, and increased circulating histamine, an
association not present in wild-type mice. Moreover, our
finding that young (4 wk) lyn /  mice showed an increased
PSA response demonstrates the enhanced potential of mast
cells to be triggered for degranulation in these mice. On
the other hand, this finding was in apparent contradiction
with the previous finding that lyn /  mice were resistant to
passive cutaneous anaphylaxis (25). We now know that the
almost complete occupancy of FcεRI by IgE as lyn /  mice
age is a likely explanation because this would prohibit the
binding of the passively transferred Ag-specific IgE, making
the response to exogenous Ag difficult. Nonetheless, it
should be noted that older lyn /  mice ( 7 wk) also
showed an impaired anaphylactic response (20–30% inhibi-
tion in serum histamine) to an anti-IgE challenge (not de-
picted), albeit not to the same extent as an Ag challenge
(50–80% inhibition). Because young mice (4 wk) respond
well to an anti-IgE challenge, the loss of responsiveness in
older mice may reflect constitutive IgE-mediated mast cell
degranulation (as reflected by increased serum histamine
levels before a challenge), or could also reflect that the lev-
els of IgE in vivo are increased to the extent where an ex-
cess of fivefold of anti-IgE to serum IgE concentrations is
not sufficient to elicit a full response. Our studies also show
that occupancy of  4 but  14% of receptors with Ag-spe-
cific IgE was sufficient to elicit an effective anaphylactic re-
sponse in lyn /  mice that was comparable to wild-type
mice, where 23–41% of the receptors were available to Ag-
specific IgE. This is consistent with our previous in vitro
studies showing that low occupancy of FcεRI can elicit
mast cell activation and functional responses (35). How-
ever, unlike the potent lymphokine responses observed,
potent degranulation was not a feature of 14% of receptor
occupancy in vitro. Thus, the in vivo results likely reflect
the hypersensitivity of mast cells in lyn /  mice and the
lowered threshold to elicit the signals necessary for degran-
ulation. Alternatively, this apparent discrepancy might be
explained by differences in the in vivo microenvironment
in which the mast cells reside (36, 37), as it may serve toLyn Negatively Regulates the Allergic Response 1500
prime lyn /  mast cells to respond more potently with less
allergen-specific IgE-occupied receptors.
One mechanism by which Src PTK activity is down-
regulated occurs through phosphorylation of an inhibitory
(i.e., Y508/528) tyrosine residue located at the COOH
terminus of the catalytic domain, which promotes an auto-
inhibitory interaction with its SH2 domain and a closed in-
active kinase conformation (38). Csk, which is responsible
for the Y508/528 phosphorylation, is a cytoplasmic kinase
that is targeted to the plasma membrane by its SH2 domain
interaction with the phosphorylated adaptor protein, Cbp
(20, 21). Thus, loss of Cbp phosphorylation (as seen in
Lyn-deficient mast cells) is likely to increase the fraction of
Src PTKs in an active state. Our findings show that Fyn is
highly active in the absence of Cbp phosphorylation. This
is demonstrated by increased Fyn activity in an autophos-
phorylation assay as well as by increased phosphorylation of
the activation loop Y417 relative to the inhibitory Y528
(Fig. S1). Evidence for preferential phosphorylation of the
equivalent activation loop tyrosine on Lyn kinase (Y397),
as reflective of an activated state, was recently provided by
a study demonstrating that Lyn kinase in the lipid raft frac-
tion of RBL-2H3 cells (39) is highly active and predomi-
nantly phosphorylated at Y397. Interestingly, active Lyn in
lipid rafts is not a consequence of FcεRI engagement be-
cause active Lyn was detected in resting cells and its activity
was not changed by FcεRI engagement (1, 39, 40). This is
consistent with the view that Lyn phosphorylates the lipid
raft resident protein Cbp in resting mast cells (Fig. 3). The
increased phosphorylation of Cbp, upon FcεRI engage-
ment, might be a consequence of additional recruitment of
Lyn (41) or possibly the activation of Syk. This increase in
Cbp phosphorylation causes additional recruitment of Csk,
which may serve to control the amount of active Fyn and
thus controls degranulation. This view is supported by the
reconstitution experiments, where introduction of rela-
tively normal levels of Lyn in Lyn-deficient mast cells re-
stored FcεRI-dependent control of Fyn activation and re-
duced the overall activity of Fyn kinase. Additionally, the
kinetics of pY417/pY528 phosphorylation seen in wild-
type cells (Fig. S1) also support this view because peak
Y417 phosphorylation was seen at 1 min after stimulation
and decreased at 3 and 9 min after stimulation. Finally, sup-
port is also provided by the previous observation that over-
expression of Cbp had a substantial inhibitory effect on
mast cell degranulation (22).
Both positive and negative roles for Lyn kinase have
been described (5–7, 25, 42-44). CD19-deficient B cells
are known to be hyporesponsive, whereas the Ig hyperre-
sponsiveness is seen in Lyn-deficient B cells (5, 25). B cells
from doubly deficient mice (CD19 /  lyn / ) showed a
suppressed Ig hyperresponsiveness (44). This correlated
with Fyn kinase activity, which was defective in CD19 and
CD19/Lyn double-deficient B cells but was intact in Lyn-
deficient B cells. This raised the possibility that Lyn-defi-
cient B cell Ig hyperresponsiveness is driven, at least in part,
by Fyn kinase. This hypothesis was also supported by the
observed reduction of IgG3 autoantibodies in fyn / -MRL/
lpr mice, which led to a marked reduction in autoimmune
disease and an increased lifespan compared with the MRL/
lpr mouse (45). Therefore, we explored whether the high
serum IgE levels in lyn /  mice might be driven by Fyn ki-
nase. Analysis of serum IgE concentrations for wild-type,
fyn / , lyn / , and lyn /  fyn /  mice revealed that the ab-
sence of Fyn had no effect on IgE levels, regardless of
whether the mice express Lyn or not. Thus, the negative
regulatory role for Lyn in B cell–mediated IgE production
is independent of its control of Fyn kinase activity. Re-
cently, it was reported that Lyn-deficient mast cells have
increased proliferative responses (33), raising the possibility
that Fyn kinase might drive this response. We can now
conclude that the increased activity of Fyn kinase in Lyn-
deficient mast cells is not responsible for the increased mast
cell numbers in lyn /  mice, as our preliminary experi-
ments also showed increased mast cell numbers in older
lyn /  fyn /  mice.
Herein, we demonstrate that Lyn deficiency has broad
consequences with respect to the allergic response. We find
that Lyn negatively controls both B cell and mast cell re-
sponsiveness in a manner that directly impacts IgE-depen-
dent activation of mast cells both in vitro and in vivo. Al-
though the etiology of the allergic-like phenotype of Lyn
deficiency is not completely clear, an increase in allergy-
associated risk factors is clearly demonstrated. Given the
present evidence of a negative regulatory role for Lyn in
mast cell responses both in vivo and in vitro, one is led to
conclude that Lyn kinase primarily functions as a negative
regulator of the IgE-mediated allergic response. This brings
into question the usefulness of therapeutically targeting this
kinase in allergic disease.
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